BOLCHINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 123
AS - Asia 110
EU - Europa 41
SA - Sud America 24
AF - Africa 1
Totale 299
Nazione #
US - Stati Uniti d'America 111
SG - Singapore 51
CN - Cina 23
BR - Brasile 22
HK - Hong Kong 12
CA - Canada 9
TR - Turchia 7
VN - Vietnam 7
BD - Bangladesh 6
IT - Italia 6
DE - Germania 5
PL - Polonia 5
RU - Federazione Russa 5
GB - Regno Unito 4
NL - Olanda 3
FI - Finlandia 2
FR - Francia 2
IE - Irlanda 2
IN - India 2
LT - Lituania 2
MX - Messico 2
UA - Ucraina 2
AR - Argentina 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
LV - Lettonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
VE - Venezuela 1
Totale 299
Città #
Singapore 31
Ashburn 16
Hong Kong 12
Los Angeles 12
The Dalles 9
Istanbul 6
Beijing 5
Chicago 5
Warsaw 5
Ho Chi Minh City 4
Houston 3
Montreal 3
Munich 3
Orem 3
San Francisco 3
Boston 2
Buffalo 2
Catania 2
Charlotte 2
Chennai 2
Dallas 2
Denver 2
Dublin 2
New York 2
Ottawa 2
Phoenix 2
Portsmouth 2
Santa Clara 2
Seattle 2
Shijiazhuang 2
Toronto 2
Turku 2
Americana 1
Amsterdam 1
Annaba 1
Antalya 1
Araçatuba 1
Basra 1
Belo Horizonte 1
Belém 1
Bratislava 1
Brooklyn 1
Butiá 1
Caracas 1
Dearborn 1
Dulles 1
Düsseldorf 1
Elk Grove Village 1
Feira de Santana 1
Frankfurt am Main 1
Fuzhou 1
Grand Rapids 1
Guarulhos 1
Haiphong 1
Hangzhou 1
Hanoi 1
Igarapé 1
Itabira 1
Itabirito 1
Jackson 1
Joinville 1
João Pessoa 1
Kryvyi Rih 1
Lanús 1
London 1
Maracanaú 1
Mexico City 1
Miami 1
Ninh Bình 1
Pederneiras 1
Pedro Leopoldo 1
Pirapora 1
Pittsburgh 1
Ponta Porã 1
Porto Alegre 1
Poá 1
Redondo Beach 1
Riga 1
San Salvador 1
Sirajganj 1
São Paulo 1
The Bronx 1
Tokyo 1
Ubá 1
Vancouver 1
Vespasiano 1
Xingtai 1
Totale 209
Nome #
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 59
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 59
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 55
Photophobia and migraine outcome during treatment with galcanezumab 47
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 45
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 40
Totale 305
Categoria #
all - tutte 1.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025138 0 0 0 30 13 12 13 7 11 13 23 16
2025/2026167 27 34 14 49 40 3 0 0 0 0 0 0
Totale 305